Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINE1 | P05121 | 1/20 | 0.83 |
| ▸ | MYC | P01106 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 5/20 | 0.42 |
| ▸ | ACMSD | Q8TDX5 | 3/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.42 |
| ▸ | DHFR | P00374 | 1/20 | 0.42 |
| ▸ | HNF4A | P41235 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 3/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fendosal SCHEMBL29657503 | 1.00 | SERPINE1 (0.83) | SERPINE1MYCLMNASMN1; SMN2GAA | |
| Fendosal SCHEMBL29753937 | 1.00 | SERPINE1 (0.83) | SERPINE1MYCLMNASMN1; SMN2GAA | |
| Fendosal SCHEMBL4270364 | 0.97 | SERPINE1 (0.78) | SERPINE1MYCLMNASMN1; SMN2GAA | |
| SCHEMBL12091803 | 0.93 | SERPINE1 (0.72) | SERPINE1MYCLMNASMN1; SMN2GAA | |
| SCHEMBL12608933 | 0.91 | SERPINE1 (0.73) | SERPINE1MYCLMNASMN1; SMN2GAA | |
| SCHEMBL2985720 | 0.91 | SERPINE1 (1.00) | SERPINE1MYCLMNASMN1; SMN2GAA | |
| SCHEMBL12091800 | 0.90 | SERPINE1 (0.68) | SERPINE1MYCLMNASMN1; SMN2GAA | |
| SCHEMBL2988538 | 0.89 | SERPINE1 (0.69) | SERPINE1MYCLMNASMN1; SMN2GAA | |
| SCHEMBL11829465 | 0.88 | SERPINE1 (0.69) | SERPINE1MYCLMNASMN1; SMN2HPGD | |
| Fendosal SCHEMBL6337926 | 0.88 | SERPINE1 (0.66) | SERPINE1MYCLMNASMN1; SMN2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9221 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713445-A2 | RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR (TPA) FRAGMENTS AND USES THEREOF | Versiti Blood Research Institute Foundation, Inc. (US) | 2026-03-25 | — | — | EP | claimed |
| EP-4470565-A1 | METHOD FOR PREVENTING OR TREATING DISEASE OR DISORDER ASSOCIATED WITH ANTINEOPLASTIC AGENT | OnQuality Pharmaceuticals China Ltd. (CN) | 2024-12-04 | — | — | EP | claimed |
| WO-2024238942-A2 | RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR (TPA) FRAGMENTS AND USES THEREOF | VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION, INC. (US) | 2024-11-21 | — | — | WO | claimed |
| EP-4442241-A2 | RETINOL REPLACEMENT IN SKIN TREATMENT | Symrise AG (DE) | 2024-10-09 | — | — | EP | claimed |
| CN-118742325-A | Methods for preventing or treating diseases or conditions associated with antineoplastic agents | 上海岸阔医药科技有限公司 | 2024-10-01 | — | — | CN | claimed |
| EP-3773445-B1 | RETINOL REPLACEMENT IN SKIN TREATMENT | SYMRISE AG (DE) | 2024-07-24 | — | — | EP | claimed |
| EP-4335413-A2 | PROSTHETIC TISSUE VALVES | Cormatrix Cardiovascular, Inc. (US) | 2024-03-13 | — | — | EP | claimed |
| US-20240041935-A1 | PREVENTION AND TREATMENT OF REPRODUCTIVE FAILURE BY REGENERATIVE CELLS AND ADJUVANTS | CREATIVE MEDICAL TECHNOLOGIES, INC. (US) | 2024-02-08 | — | — | US | claimed |
| WO-2023212179-A2 | THERAPEUTIC COMPOSITIONS FOR SKIN DISORDERS AND WOUND REPAIR | UNIVERSITY OF MIAMI (US) | 2023-11-02 | — | — | WO | claimed |
| WO-2023142996-A1 | METHOD FOR PREVENTING OR TREATING DISEASE OR DISORDER ASSOCIATED WITH ANTINEOPLASTIC AGENT | 上海岸阔医药科技有限公司 | 2023-08-03 | — | — | WO | claimed |
| WO-1993010847-A1 | METHOD OF REDUCING MEDICAL DEVICE RELATED INFECTIONS | NORTH SHORE UNIVERSITY HOSPITAL RESEARCH CORPORATION (US) | 1993-06-10 | — | — | WO | claimed |
| WO-1993010756-A1 | USE OF SALICYLIC ACID FOR REGULATING SKIN WRINKLES AND/OR SKIN ATROPHY | RICHARDSON-VICKS, INC. (US) | 1993-06-10 | — | — | WO | claimed |
| EP-0537313-A1 | ARYLALKYL ESTERS OF 4,5-DIHYDROXY-9,10-DIHYDRO-9,10-DIOXO-2-ANTHRACENECARBOXYLIC ACID HAVING THERAPEUTICAL ACTIVITY. | GENTILI IST SPA (IT) | 1993-04-21 | — | — | EP | claimed |
| WO-1992019584-A1 | ARYLALKYL ESTERS OF 4,5-DIHYDROXY-9,10-DIHYDRO-9,10-DIOXO-2-ANTHRACENECARBOXYLIC ACID HAVING THERAPEUTICAL ACTIVITY | ISTITUTO GENTILI S.P.A. (IT) | 1992-11-12 | — | — | WO | claimed |
| WO-1992013864-A1 | ACYLAMINO-ALKYLIDEN-HYDROXY-BISPHOSPHONIC ACIDS USEFUL IN THE THERAPY OF OSTEOARTICULAR DISEASES | ISTITUTO GENTILI S.P.A. (IT) | 1992-08-20 | — | — | WO | claimed |
| EP-0466650-A2 | Improvements in non-steroidal anti-inflammatory therapy | WARNER-LAMBERT COMPANY (US) | 1992-01-15 | — | — | EP | claimed |
| US-RE30809-E | Method of preparation of 3-(3-carboxy-4-hydroxyphenyl)-4,5-dihydro-2-phenylbenz [e]indole and valuable intermediates related thereto | AMERICAN HOECHST CORPORATION (US) | 1981-12-01 | — | — | US | claimed |
| US-4066659-A | METHOD OF PREPARATION OF 3-(3-CARBOXY-4-HYDROXYPHENYL)-4,5-DIHYDRO-2-PHENYLBENZ (E) INDOLE AND VALUABLE INTERMEDIATES RELATED THERETO | AMERICAN HOECHST CORPORATION (US) | 1978-01-03 | — | — | US | claimed |
| US-4056624-A | SUBSTITUTED BENZINDOLE | AMERICAN HOECHST CORPORATION (US) | 1977-11-01 | — | — | US | claimed |
| US-3931407-A | ANTIINFLAMMATORY, ANALGESIC | AMERICAN HOECHST CORPORATION (US) | 1976-01-06 | — | — | US | claimed |